Long-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patients

Takakuwa,Osamu; Oguri,Tetsuya; Maeno,Ken; Murase,Hiroki; Asano,Takamitsu; Ichikawa,Hiroya; Kawaguchi,Yuko; Uemura,Takehiro; Ohkubo,Hirotsugu; Takemura,Masaya; Niimi,Akio

doi:10.3892/ol.2015.3022

May-2015 Volume 9 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2015 Volume 9 Issue 5

Full Size Image

Article

Long-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patients

Authors:
- Osamu Takakuwa
- Tetsuya Oguri
- Ken Maeno
- Hiroki Murase
- Takamitsu Asano
- Hiroya Ichikawa
- Yuko Kawaguchi
- Takehiro Uemura
- Hirotsugu Ohkubo
- Masaya Takemura
- Akio Niimi
View Affiliations / Copyright

Affiliations: Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan
Pages: 2105-2108
|
Published online on: March 9, 2015

https://doi.org/10.3892/ol.2015.3022
Expand metrics +

Abstract

Transdermal fentanyl is widely administered as an analgesic therapy for cancer patients. Recently, a novel fentanyl citrate transdermal patch was developed in Japan, which is the first such patch that requires changing only once a day. The patch releases more stable serum fentanyl concentrations and results in less frequent adverse skin symptoms compared with the conventional 72‑h transdermal fentanyl patch. A previous study has reported the short‑term analgesic effects and safety of this transdermal patch. However, the long‑term efficacy has yet to be determined. Therefore, the present study retrospectively investigated the adverse effects and outcomes of treatment with this product in 46 lung cancer patients. In total, 35 (76%) patients were able to continue the treatment until the end of the observation period, including 32 (69%) who succumbed to the disease and three (7%) who were transferred from Nagoya City University Hospital to a hospice. Of the 11 (24%) discontinued cases, six were changed to a course of injectable opioids for the palliation of terminal symptoms, including dyspnea. Adverse effects were observed in 11 (24%) cases, but discontinuation due to adverse effects occurred in only four cases. Therefore, the present study indicates that palliative treatment with the once‑a‑day fentanyl citrate transdermal patch is well‑tolerated by lung cancer patients.

View Figures

View References

1	Cleeland CS, Gonin R, Hatfield AK, et al: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 330:592–596. 1994. View Article : Google Scholar : PubMed/NCBI
2	van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M and Patijn J: Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 18:1437–1449. 2007. View Article : Google Scholar : PubMed/NCBI
3	World Health Organization. Cancer pain relief: with a guide to opiod availability. 2nd edition. World Health Organization; Geneva, Switzerland: pp. 12–38. 1996
4	Mercadante S, Porzio G, Ferrera P, et al: Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 12:1040–1046. 2008. View Article : Google Scholar : PubMed/NCBI
5	Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R and Mahmoud R: Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol. 4:1588–1593. 1998.
6	Caraceni A, Hanks G, Kaasa S, et al: European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC): Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 13:e58–e68. 2012. View Article : Google Scholar : PubMed/NCBI
7	National Collaborating Centre for Cancer (UK). Opioids in Palliative Care: Safe and Effective Prescribing of Strong Opioids for Pain in Palliative Care of Adults. (Cardiff (UK)). National Collaborating Centre for Cancer (UK); National Institute for Health and Clinical Excellence. Guidance. May;2012.
8	Hanks GW, Conno F, Cherny N, et al: Expert Working Group of the Research Network of the European Association for Palliative Care: Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 84:587–593. 2001. View Article : Google Scholar : PubMed/NCBI
9	Miyazaki T, Namiki A, Ogawa S, et al: A phase II clinical study of once-a-day fentanyl citrate patch in patients with cancer pain - switching from once-every-three-days fentanyl patch to once-a-day fentanyl citrate patch. Gan To Kagaku Ryoho. 37:1747–1752. 2010.[In Japanese]. PubMed/NCBI
10	Takakuwa O, Oguri T, Maeno K, et al: Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancer. Am J Hosp Palliat Care. 30:726–729. 2013. View Article : Google Scholar : PubMed/NCBI
11	National Cancer Institute Common Toxicity Criteria version 4.0. http://evs.nci.nih.gov/ftp1/CTCAE/About.htmlApril 17–2012
12	Shimizu Y, Nagaya N, Isobe T, et al: Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res. 9:774–778. 2003.PubMed/NCBI
13	Vigano A, Donaldson N, Higginson IJ, et al: Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer. 101:1090–1098. 2004. View Article : Google Scholar : PubMed/NCBI
14	Bruera E, MacEachern T, Ripamonti C and Hanson J: Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med. 119:906–907. 1993. View Article : Google Scholar : PubMed/NCBI
15	Mazzocato C, Buclin T and Rapin CH: The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol. 10:1511–1514. 1999. View Article : Google Scholar : PubMed/NCBI
16	Pinna MA, Bruera E, Moralo MJ, Correas MA and Vargas RM: A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer. Am J Hosp Palliat Care. Nov 20–2013.(Epub ahead of print). PubMed/NCBI
17	Claessens MT, Lynn J, Zhong Z, et al: Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc. 48:Suppl. S146–S153. 2000. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Long-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patients

This article is mentioned in:

Abstract

Related Articles